Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Seabra

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
ACS Medicinal Chemistry Letters|May 14, 2025
Virtual High-Throughput Screening of Ligands for Disrupting PRMT5/pICLn Interaction in Prostate Cancer CellsZhihang Shen, Gustavo Seabra, Chenglong Li
Journal of Chemical Information and Modeling|April 5, 2014
Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzymeCarlos H B da Cruz, Gustavo Seabra
Molecular Pharmaceutics|June 29, 2023
Molecular Recognition Study toward the Mitochondrial Electron Transport Chain Inhibitor Mubritinib and Human Serum AlbuminThais Meira Menezes, Gustavo Seabra, Jorge Luiz Neves
RSC Medicinal Chemistry|April 28, 2025
Grassystatin G, a new cathepsin D inhibitor from marine cyanobacteria: discovery, synthesis, and biological characterizationLobna A Elsadek, Gustavo Seabra, Valerie J Paul, et al.
Arxiv|December 3, 2025
Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion ModelsXinzhe Zheng, Shiyu Jiang, Gustavo Seabra, et al.
Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence|May 11, 2026
Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion ModelsXinzhe Zheng, Shiyu Jiang, Gustavo Seabra, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 18, 2024
Isolation, Structure Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine CyanobacteriumSofia Kokkaliari, Laura Grauso, Alfonso Mangoni, et al.
Marine Drugs|January 22, 2024
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 SelectivityLobna A Elsadek, Emma K Ellis, Gustavo Seabra, et al.
ACS Medicinal Chemistry Letters|July 17, 2024
Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico StudyYuzhao Zhang, Meijun Xiong, Zixin Chen, et al.
ACS Omega|January 20, 2025
Discovery of PRMT5 N-Terminal TIM Barrel Ligands from Machine-Learning-Based Virtual ScreeningZhihang Shen, Gustavo Seabra, Jason Brant, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
ACS Medicinal Chemistry Letters|May 14, 2025
Virtual High-Throughput Screening of Ligands for Disrupting PRMT5/pICLn Interaction in Prostate Cancer CellsZhihang Shen, Gustavo Seabra, Chenglong Li
Journal of Chemical Information and Modeling|April 5, 2014
Molecular dynamics simulations reveal a novel mechanism for ATP inhibition of insulin degrading enzymeCarlos H B da Cruz, Gustavo Seabra
Molecular Pharmaceutics|June 29, 2023
Molecular Recognition Study toward the Mitochondrial Electron Transport Chain Inhibitor Mubritinib and Human Serum AlbuminThais Meira Menezes, Gustavo Seabra, Jorge Luiz Neves
RSC Medicinal Chemistry|April 28, 2025
Grassystatin G, a new cathepsin D inhibitor from marine cyanobacteria: discovery, synthesis, and biological characterizationLobna A Elsadek, Gustavo Seabra, Valerie J Paul, et al.
Arxiv|December 3, 2025
Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion ModelsXinzhe Zheng, Shiyu Jiang, Gustavo Seabra, et al.
Proceedings of the ... AAAI Conference on Artificial Intelligence. AAAI Conference on Artificial Intelligence|May 11, 2026
Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion ModelsXinzhe Zheng, Shiyu Jiang, Gustavo Seabra, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 18, 2024
Isolation, Structure Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine CyanobacteriumSofia Kokkaliari, Laura Grauso, Alfonso Mangoni, et al.
Marine Drugs|January 22, 2024
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 SelectivityLobna A Elsadek, Emma K Ellis, Gustavo Seabra, et al.
ACS Medicinal Chemistry Letters|July 17, 2024
Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico StudyYuzhao Zhang, Meijun Xiong, Zixin Chen, et al.
ACS Omega|January 20, 2025
Discovery of PRMT5 N-Terminal TIM Barrel Ligands from Machine-Learning-Based Virtual ScreeningZhihang Shen, Gustavo Seabra, Jason Brant, et al.
Pageof 4